PT-141 is a melanocortin receptor agonist derived from Melanotan II, studied for its influence on sexual function via the central nervous system rather than through the vascular system.

Research Focus:

• Libido and sexual arousal studies
• Male erectile function research
• Female sexual dysfunction models
• Central melanocortin system modulation

Sources:

FDA label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf

Approval summary/clinical pharmacology (FDA Review): https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/210557Orig1s000ClinPharmR.pdf

Mechanism/safety (LiverTox): https://www.ncbi.nlm.nih.gov/books/NBK573221/

⚠️ Disclaimer: For research use only. Not intended for human consumption. This information is provided for educational purposes and has not been evaluated by the FDA.